Jack Kaye

Director/Board Member at DYADIC INTERNATIONAL, INC.

Net worth: 664 198 $ as of 2026-09-29

81 year

82 connections

Health Technology

Distribution Services

Health Services

Profile

Jack L.
Kaye is currently an Independent Director at Dyadic International, Inc. since 2015, an Independent Non-Executive Director at uniQure NV since 2016, a Director at DiaCarta, Inc. since 2022, and a Director at Tda Industries, Inc. since 2024.
Formerly, Mr. Kaye was an Independent Director at Keryx Biopharmaceuticals, Inc. from 2011 to 2016, a Director at Balboa Biosciences, Inc., an Independent Director at Tongli Pharmaceuticals (USA), Inc., and a Partner at Deloitte LLP (New York) from 1978 to 2006.
Education includes undergraduate studies at Baruch College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
UNIQURE N.V. 0.04%	2026-06-29	25,996 ( 0.04% )	628 063 $	2026-09-29
DYADIC INTERNATIONAL, INC. 0.2%	2026-04-23	81,201 ( 0.2% )	36 134 $	2026-09-29

Jack Kaye active positions

Companies	Position	Start
DYADIC INTERNATIONAL, INC.	Director/Board Member	2015-04-30
UNIQURE N.V.	Director/Board Member	2016-06-14
DiaCarta, Inc. DiaCarta, Inc. BiotechnologyHealth Technology Operates as a translational genomics and precision molecular diagnostics company	Director/Board Member	2022-04-06
Tda Industries, Inc. Tda Industries, Inc. Wholesale DistributorsDistribution Services Manufactures roofing, siding, and insulation materials	Director/Board Member	2024-01-31

All active positions of Jack Kaye

Former positions of Jack Kaye

Companies	Position	End
KERYX BIOPHARMACEUTICALS	Director/Board Member	2016-05-24
TONGLI PHARMACEUTICALS (USA), INC.	Director/Board Member	2009-06-18
Deloitte LLP (New York) Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax preparation and financial advisory services	Corporate Officer/Principal	2006-04-30
Balboa Biosciences, Inc. Balboa Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics for central nervous system disorders	Director/Board Member	-

See the detail of Jack Kaye's experience

Education of Jack Kaye

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jack Kaye's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Tda Industries, Inc. Tda Industries, Inc. Wholesale DistributorsDistribution Services Manufactures roofing, siding, and insulation materials	Distribution Services
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease	Health Technology
Dyadic International, Inc. Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products	Health Services
Deloitte LLP (New York) Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax preparation and financial advisory services	Commercial Services
Baruch College Baruch College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Balboa Biosciences, Inc. Balboa Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics for central nervous system disorders	Health Technology
Tongli Pharmaceuticals (USA), Inc. Tongli Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical and health care products	Health Technology
uniQure NV uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products	Health Technology
DiaCarta, Inc. DiaCarta, Inc. BiotechnologyHealth Technology Operates as a translational genomics and precision molecular diagnostics company	Health Technology